arrow
A

Abraham Guerrero

astellas pharma global development inc.
H指数:18
被引数:1,047

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Zolbetuximab plus chemotherapy in Japanese patients with claudin 18.2–positive gastric or gastroesophageal junction adenocarcinoma: a combined subgroup analysis of the phase 3 SPOTLIGHT and GLOW trials

Zolbetuximab联合化疗在日本Claudin 18.2阳性胃癌或胃食管结合部腺癌患者中的应用:SPOTLIGHT和GLOW III期试验的合并亚组分析

2026-05-070
OAAI
First-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a phase 2 trial

一线zolbetuximab联合mFOLFOX6和nivolumab治疗不可切除的CLDN18.2阳性胃或胃食管结合部腺癌:一项Ⅱ期临床试验

2026-03-160
OAAI
Global prevalence of claudin 18 isoform 2 in tumors of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma

局部晚期不可切除或转移性胃或胃食管交界处腺癌患者肿瘤中claudin 18亚型2的全球患病率

2024-07-026
OAAI
Extended-Spectrum β-Lactamase-Producing Escherichia coli Isolated from Food-Producing Animals in Tamaulipas, Mexico

从墨西哥塔毛利帕斯州的食用动物中分离出的产超广谱 β-内酰胺酶的大肠杆菌

2023-06-055
OA